← Evidence map

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Reply to Masters: Recombinant coronavirus balances biosafety and benefit.

Jonathan W YewdellPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 39432797